MD Medical Group’s (MDMG) director of finance Andrew Khoperskiy will be taking on the role of deputy chief exeucitve for economics and finance, replacing Vitalii Ustimenko.

The changes will take effect as of 28 October 2016.

Ustimenko will still remain on the board of the Russian private healthcare provider.

MDMG chief executive Mark Kurtser said: "I want to personally thank Vitalii for everything that he has contributed to the Group since he joined us back in 2012. This included supporting our successful IPO on the London Stock Exchange as well as developing our finance function in a period of sustained, rapid growth, when we saw revenue increase from RUB 3 billion to RUB 9.5 billion, and as we built MDMG into the largest national private healthcare provider in Russia.”

He added that Khoperskiy has “an outstanding understanding of the business and thanks to his professional skills and knowledge, is the ideal candidate to take on this position going forward”.